Global Medical REIT Inc. (NYSE:XRN – Get Free Report) Director Paula Crowley acquired 1,000 shares of the business’s stock in a transaction on Monday, May 11th. The stock was purchased at an average price of $34.00 per share, for a total transaction of $34,000.00. Following the acquisition, the director directly owned 1,000 shares in the company, valued at $34,000. This represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
Global Medical REIT Stock Performance
Shares of XRN stock opened at $34.35 on Thursday. Global Medical REIT Inc. has a 12 month low of $29.05 and a 12 month high of $39.93. The company has a debt-to-equity ratio of 1.68, a current ratio of 0.68 and a quick ratio of 0.61. The firm has a market capitalization of $454.56 million, a P/E ratio of -30.94 and a beta of 1.11. The company’s fifty day moving average price is $35.01 and its two-hundred day moving average price is $34.46.
Global Medical REIT Dividend Announcement
The business also recently announced a monthly dividend, which will be paid on Friday, September 18th. Stockholders of record on Thursday, August 20th will be paid a $0.16 dividend. This represents a c) dividend on an annualized basis and a dividend yield of 5.6%. The ex-dividend date is Thursday, August 20th. Global Medical REIT’s dividend payout ratio is -270.27%.
Institutional Investors Weigh In On Global Medical REIT
Wall Street Analyst Weigh In
XRN has been the topic of a number of recent analyst reports. Weiss Ratings lowered shares of Global Medical REIT from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Monday. Wall Street Zen lowered shares of Global Medical REIT from a “hold” rating to a “sell” rating in a research note on Saturday, May 9th. Finally, Compass Point restated a “neutral” rating and issued a $38.00 target price (down from $50.00) on shares of Global Medical REIT in a research note on Thursday, May 7th. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Global Medical REIT currently has a consensus rating of “Moderate Buy” and an average price target of $39.67.
View Our Latest Stock Report on XRN
About Global Medical REIT
Global Medical REIT (NYSE: GMRE) is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.
Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.
See Also
- Five stocks we like better than Global Medical REIT
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.
